UBC13, also known as ubiquitin-conjugating enzyme E2 13, is a key component of the ubiquitin-proteasome system (UPS), which regulates protein degradation and turnover in eukaryotic cells. UBC13 functions as an E2 ubiquitin-conjugating enzyme, playing a critical role in the synthesis of K63-linked polyubiquitin chains. These chains serve as important signaling molecules involved in various cellular processes, including DNA repair, immune response, and signal transduction. One of the primary functions of UBC13 is its involvement in the DNA damage response pathway, where it collaborates with the E3 ubiquitin ligase complex to mediate the formation of K63-linked polyubiquitin chains on target proteins. This modification facilitates the recruitment of DNA repair factors to sites of DNA damage, promoting efficient repair and maintenance of genomic integrity.
The activation of UBC13 is tightly regulated to ensure proper functioning of the UPS and cellular homeostasis. One mechanism of UBC13 activation involves its interaction with specific E3 ubiquitin ligases, which facilitate the transfer of ubiquitin from the E2 enzyme to target proteins. Additionally, post-translational modifications such as phosphorylation, acetylation, and SUMOylation may modulate UBC13 activity and stability, influencing its ability to catalyze the formation of K63-linked polyubiquitin chains. Furthermore, the binding of cofactors or adaptor proteins may enhance the catalytic activity of UBC13 or promote its recruitment to specific substrates, thereby regulating its function in various cellular pathways. Overall, the precise activation of UBC13 is essential for its role in mediating protein ubiquitination and contributing to diverse cellular processes critical for cell survival and function.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
MLN7243 | 1450833-55-2 | sc-507338 | 5 mg | $340.00 | ||
TAK-243 is an inhibitor of the NEDD8-activating enzyme (NAE) that indirectly activates UBC13. By inhibiting NAE, TAK-243 stabilizes the interaction between UBC13 and UEV1A, leading to enhanced UBC13 activation in the context of NEDD8 conjugation and associated cellular processes. | ||||||
NSC697923 | 343351-67-7 | sc-391107 sc-391107A | 1 mg 5 mg | $15.00 $52.00 | 3 | |
NSC697923 is an inhibitor of the NEDD8-activating enzyme (NAE) and can indirectly activate UBC13. Through the inhibition of NAE, NSC697923 stabilizes UBC13, promoting its involvement in cellular processes like DNA repair and immune response signaling, where UBC13 plays a crucial role. | ||||||
UNC 0642 | 1481677-78-4 | sc-397059 | 10 mg | $235.00 | 3 | |
UNC-0642 is a small-molecule inhibitor that indirectly activates UBC13 by targeting the NEDD8-activating enzyme (NAE). Its inhibitory effect on NAE leads to increased stability and activity of UBC13, facilitating its engagement in cellular processes such as DNA repair and NF-κB signaling. | ||||||
MLN 4924 | 905579-51-3 | sc-484814 | 1 mg | $286.00 | 1 | |
MLN 4924 (Pevonedistat) is an inhibitor of the NEDD8-activating enzyme (NAE), indirectly activating UBC13. Its action on NAE results in the stabilization of UBC13, allowing for increased participation in cellular processes such as DNA repair and NF-κB signaling, where UBC13 is crucial for proper functioning. | ||||||